# EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial)

> **NCT06762145** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Xiao-dong Zhuang** · enrollment: 200 (estimated)

## Conditions studied

- Transcatheter Aortic Valve Replacemen
- Left Bundle Branch Block

## Interventions

- **DRUG:** Methylprednisolone (Corticosteroid)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06762145
- **Lead sponsor:** Xiao-dong Zhuang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-01-01
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-07-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06762145

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06762145, "EArly Effect of Glucocorticoid on Incidence of Persistent Left BundlE Branch Block (LBBB) Post-TAVR (EAGLE-TAVR Trial)". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06762145. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*